RXi Pharmaceuticals to Present at the BIO CEO and Investor Conference

February 5, 2018

Responsive image

MARLBOROUGH, Mass., Feb. 5, 2018 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing immuno-oncology therapeutics based on its self-delivering RNAi (sd-rxRNA®) therapeutic platform today announced that it will give a webcast presentation at…

Category: Precious Metals